Correlation Between 89bio and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both 89bio and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Blueprint Medicines Corp, you can compare the effects of market volatilities on 89bio and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Blueprint Medicines.
Diversification Opportunities for 89bio and Blueprint Medicines
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 89bio and Blueprint is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of 89bio i.e., 89bio and Blueprint Medicines go up and down completely randomly.
Pair Corralation between 89bio and Blueprint Medicines
Given the investment horizon of 90 days 89bio Inc is expected to generate 1.83 times more return on investment than Blueprint Medicines. However, 89bio is 1.83 times more volatile than Blueprint Medicines Corp. It trades about 0.12 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.19 per unit of risk. If you would invest 777.00 in 89bio Inc on August 25, 2024 and sell it today you would earn a total of 99.00 from holding 89bio Inc or generate 12.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
89bio Inc vs. Blueprint Medicines Corp
Performance |
| Timeline |
| 89bio Inc |
| Blueprint Medicines Corp |
89bio and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 89bio and Blueprint Medicines
The main advantage of trading using opposite 89bio and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| 89bio vs. Eliem Therapeutics | 89bio vs. HCW Biologics | 89bio vs. Scpharmaceuticals | 89bio vs. Milestone Pharmaceuticals |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |